{"id":"https://genegraph.clinicalgenome.org/r/f332bc55-8ea7-40bc-b28b-2149f6ce0a25v1.3","type":"EvidenceStrengthAssertion","dc:description":"The relationship between the NEU1 gene and sialidosis, an autosomal recessive lysosomal storage disorder, was evaluated using the ClinGen Clinical Validity Framework as of September 1, 2022. NEU1 encodes neuraminidase 1 (PMID: 8985184), an enzyme that is involved in degradation of sialated glyconguates via hydrolyzing terminal N-acetylated neuraminic acids (sialic acids) in oligosaccharides, glycoproteins, glycolipids, colominic acid and synthetic substrates (as reviewed in PMID: 26949572). Patients with sialidosis show deficient neuraminidase I activity (PMID: 836321, PMID: 610423), leading to accumulation of sialylated oligosaccharides and glycoproteins and urinary excretion of sialylated oligosaccharides and glycoproteins and resulting in characteristic clinical disease manifestations including skeletal anomalies, coarse facies, hepatosplenomegaly, and neurologic impairment (as reviewed in PMID: 26949572). \n\nThe disease mechanism of sialidosis is loss of function. Sialidosis was first reported in 1968 by Spranger et al. (PMID: 4235073) and the first report of biallelic variants in NEU1 among sialidosis cases was in 1996 by Bonten et al. (PMID: 8985184). Both case-level (genetic) and experimental evidence support the relationship between NEU1 and sialidosis. Reported causal variants include missense, nonsense, frameshift, and splice-altering variants (PMID: 8985184, PMID: 10767332, PMID: 9054950, PMID: 11702224, PMID: 11470272, PMID: 14695530, PMID: 18343720). In total, fourteen variants from ten probands in seven publications were curated. Although there is additional published case-level evidence available, the maximum score for genetic evidence (12 points) has already been reached. \n\nExperimental evidence for the relationship between NEU1 and sialidosis includes: the biochemical function of the gene product (neuraminidase 1) being consistent with the clinical and biochemical findings identified individuals with sialidosis (PMID: 8985184, PMID: 836321, PMID: 610423, PMID: 26949572); the biochemical and clinical features of NEU1 knockout mice (PMID: 12023988); and rescue of enzyme function via chaperone-mediated gene therapy in NEU1 transgenic mice (PMID: 23770387). Additional experimental evidence is available, but the maximum score for experimental evidence (6 points) has already been reached.\n\nIn sum, NEU1 is definitively associated with sialidosis. The association has been repeatedly demonstrated in both clinical and research settings, and has been upheld over time. This clinical validity classification was approved by the ClinGen Lysosomal Diseases GCEP on September 2, 2022 (SOP v9).\n\n**Data provided by the ClinGen Prenatal GCEP on January 28, 2025:**\nFeatures of sialidosis that can be identified prenatally by fetal imaging include hydrops, ascites, pleural effusion, cardiomegaly, pericardial effusion, and hepatosplenomegaly (PMID: 11063730, 1119501). Neonates may also have hypotonia, dysostosis multiplex, and coarse facial features (PMID: 23433491, 25223955). Stillbirth or early death in individuals with congenital sialidosis is common (PMID: 11063730, 11195014).\nNote: This addition of the data from the ClinGen Prenatal GCEP does not change the scoring or classification of the gene-disease relationship that was approved by the ClinGen Lysosomal Diseases GCEP.","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/f332bc55-8ea7-40bc-b28b-2149f6ce0a25","GCISnapshot":"https://genegraph.clinicalgenome.org/r/01f588c4-4fef-493d-b5e0-a76fb9492244","calculatedEvidenceStrength":"Definitive","changes":{"id":"cg:summaryChange"},"contributions":[{"id":"https://genegraph.clinicalgenome.org/r/01f588c4-4fef-493d-b5e0-a76fb9492244_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10110","date":"2025-04-11T16:00:00.000Z","role":"Approver"},{"agent":"https://genegraph.clinicalgenome.org/agent/10106","role":"SecondaryContributor"},{"id":"https://genegraph.clinicalgenome.org/r/01f588c4-4fef-493d-b5e0-a76fb9492244_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10110","date":"2025-04-11T20:23:23.520Z","role":"Publisher"}],"curationReasons":["ErrorClarification"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/01f588c4-4fef-493d-b5e0-a76fb9492244_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/01f588c4-4fef-493d-b5e0-a76fb9492244_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c21970cd-3cf3-4934-9284-f7b850b8d268","type":"EvidenceLine","dc:description":"Per ClinGen LD GCEP guidelines, gene products that have a well-established function in a metabolic pathway are scored 2 points","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/30afcb84-267a-4838-b6d3-ebec315b58a4","type":"Finding","dc:description":"NEU1 encodes neuraminidase I, an enzyme that is involved in degradation of sialated glyconguates via hydrolyzing terminal N-acetylated neuraminic acids (sialic acid)  in oligosaccharides, glycoproteins, glycolipids, colominic acid and synthetic substrates (as reviewed in PMID: 26949572). Patients with sialidosis show deficient neuraminidase I activity (PMID: 836321, PMID: 610423), leading to accumulation of sialylated oligosaccharides and glycoproteins and urinary excretion of sialylated oligosaccharides and glycoproteins (as reviewed in PMID: 29693572), resulting in characteristic disease manifestations including skeletal anomalies, coarse facies, hepatosplenomegaly, and neurologic impairment (as reviewed in PMID: 26949572).  Thus, the biochemical function of the NEU1 gene is consistent with the disease process. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8985184","rdfs:label":"NEU1 encodes neuraminidase 1","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/01f588c4-4fef-493d-b5e0-a76fb9492244_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b7091bcb-c8a9-4884-b4f0-90260fcee2f8","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bc57efec-1874-4afd-93e5-71e174bdb4a9","type":"Finding","dc:description":"Gene therapy-treated mice showed ~2-fold increased NEU1 enzyme activity in multiple tissues and reduced cellular vacuolization and improved tissue morphology in the kidney","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23770387","rdfs:label":"Gene therapy in NEU1 transgenic mouse","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityNonHumanRescueCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/a9fe89dc-6801-408f-bc85-c4056f761fdb","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f6d24465-8fab-4185-9e6b-d68a68db8993","type":"Finding","dc:description":"NEU1 knockout mice show severely reduced neuraminidase activity in multiple tissues, severe nephropathy, progressive edema, splenomegaly, kyphosis and urinary excretion of sialylated oligosaccharides, recapitulating key features of the human sialidosis phenotype. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12023988","rdfs:label":"NEU1 knockout mouse model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":6},{"id":"https://genegraph.clinicalgenome.org/r/01f588c4-4fef-493d-b5e0-a76fb9492244_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e5990fce-40e2-4137-80eb-3913641ffad8_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e5990fce-40e2-4137-80eb-3913641ffad8","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8985184","rdfs:label":"Patient II - Bonten","allele":[{"id":"https://genegraph.clinicalgenome.org/r/4b7e2680-f7f7-4d84-98c8-fc9d77a609fa","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NEU1, 1-BP DEL, 1337C","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/2445"}},{"id":"https://genegraph.clinicalgenome.org/r/97624256-7cd0-4d0a-9325-b447c85e72f5","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000434.4(NEU1):c.272T>G (p.Leu91Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA212557"}}],"detectionMethod":"direct sequencing of reverse transcriptase (RT)-PCR-synthesized cDNAs","firstTestingMethod":"Other","previousTesting":false,"sex":"UnknownEthnicity","variant":[{"id":"https://genegraph.clinicalgenome.org/r/1752807c-60a7-4e10-a3fd-bf08788920fc_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8985184","allele":{"id":"https://genegraph.clinicalgenome.org/r/97624256-7cd0-4d0a-9325-b447c85e72f5"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/58c03afe-68a1-48ce-9d3d-8b7dde898c71_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8985184","allele":{"id":"https://genegraph.clinicalgenome.org/r/4b7e2680-f7f7-4d84-98c8-fc9d77a609fa"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/1752807c-60a7-4e10-a3fd-bf08788920fc","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1752807c-60a7-4e10-a3fd-bf08788920fc_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/58c03afe-68a1-48ce-9d3d-8b7dde898c71","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/58c03afe-68a1-48ce-9d3d-8b7dde898c71_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/58c03afe-68a1-48ce-9d3d-8b7dde898c71_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"shown in cellular transfection experiments to result in undetectable neuraminidase activity and aberrant cellular trafficking (immunofluorescence assay showed that the variant resulted in a peptide that localized to the perinuclear region, with no lysosomal staining detected) (PMID: 8985184)","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.6},{"id":"https://genegraph.clinicalgenome.org/r/44431885-35c5-4032-af6f-8a8acc89ee6b_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/44431885-35c5-4032-af6f-8a8acc89ee6b","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10767332","rdfs:label":"Patient 6","allele":{"id":"https://genegraph.clinicalgenome.org/r/557d9e33-c316-4f4c-9b42-e17d775cf123","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000434.4(NEU1):c.203G>T (p.Gly68Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA363496575"}},"firstTestingMethod":"PCR","previousTesting":false,"secondTestingMethod":"SSCP","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/2262019a-5603-4422-bdf6-8e8d86a7b723_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10767332","allele":{"id":"https://genegraph.clinicalgenome.org/r/557d9e33-c316-4f4c-9b42-e17d775cf123"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/2262019a-5603-4422-bdf6-8e8d86a7b723","type":"EvidenceLine","dc:description":"scored 0.25pts per variant to yield 0.5pts total and prevent double-counting for homozygous variant","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2262019a-5603-4422-bdf6-8e8d86a7b723_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/2262019a-5603-4422-bdf6-8e8d86a7b723_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"PMID: 10767332: in COS-7 cells transfected with the variant, resulted in <10% of wild-type sialidase enzyme activity","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/a437b4ac-7294-4a61-a6bf-8f015e7b4840_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a437b4ac-7294-4a61-a6bf-8f015e7b4840","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11702224","rdfs:label":"Patient 1 - Sergi","allele":{"id":"https://genegraph.clinicalgenome.org/r/01d6632c-72b1-4d10-82d0-60b0c16e3bc1","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000434.4(NEU1):c.87G>A (p.Trp29Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA212560"}},"firstTestingMethod":"PCR","previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/02955066-5163-4d6b-8e97-8c2af851404b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11702224","allele":{"id":"https://genegraph.clinicalgenome.org/r/01d6632c-72b1-4d10-82d0-60b0c16e3bc1"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/02955066-5163-4d6b-8e97-8c2af851404b","type":"EvidenceLine","dc:description":"Scored 0.75pts per variant to yield 1.5pts total and prevent double-counting for homozygous variant","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/02955066-5163-4d6b-8e97-8c2af851404b_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/05981deb-8536-4ace-9dac-0520f20c2916_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/05981deb-8536-4ace-9dac-0520f20c2916","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18343720","rdfs:label":"Patient 1 - Huang","allele":[{"id":"https://genegraph.clinicalgenome.org/r/5997d5c0-5cf9-40a8-ac8d-795f7984609b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000434.4(NEU1):c.163C>T (p.Gln55Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA3725081"}},{"id":"https://genegraph.clinicalgenome.org/r/3c59255c-486a-4e37-b616-15bebd1221d1","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000434.4(NEU1):c.544A>G (p.Ser182Gly)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA3725021"}}],"detectionMethod":"Genetic testing method not specified ","firstTestingMethod":"Other","previousTesting":false,"sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/b1ea48fe-13b1-4f0f-8adb-384dbf54ecbc_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18343720","allele":{"id":"https://genegraph.clinicalgenome.org/r/3c59255c-486a-4e37-b616-15bebd1221d1"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/ffeca745-f0b0-45eb-a8fe-feb0569d25cf_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18343720","allele":{"id":"https://genegraph.clinicalgenome.org/r/5997d5c0-5cf9-40a8-ac8d-795f7984609b"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/b1ea48fe-13b1-4f0f-8adb-384dbf54ecbc","type":"EvidenceLine","dc:description":"Downgraded to 0.1 given that enzymatic assay showed reduced but still some residual activity","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b1ea48fe-13b1-4f0f-8adb-384dbf54ecbc_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/b1ea48fe-13b1-4f0f-8adb-384dbf54ecbc_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"PMID: 10767332: resulted in 40% of wild-type enzyme activity in transfected COS-7 cells ","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/ffeca745-f0b0-45eb-a8fe-feb0569d25cf","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ffeca745-f0b0-45eb-a8fe-feb0569d25cf_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.6},{"id":"https://genegraph.clinicalgenome.org/r/c7c75e1d-b882-470b-b4c9-a1ac341f92af_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c7c75e1d-b882-470b-b4c9-a1ac341f92af","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14695530","rdfs:label":"Patient C - Pattinson","allele":{"id":"https://genegraph.clinicalgenome.org/r/39d2adca-bca8-48a0-9771-70179c479b86","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000434.4(NEU1):c.69G>A (p.Trp23Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA212566"}},"firstTestingMethod":"PCR","previousTesting":false,"secondTestingMethod":"Restriction digest","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/c7def945-1888-42fc-8d28-e1463f15da5b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14695530","allele":{"id":"https://genegraph.clinicalgenome.org/r/39d2adca-bca8-48a0-9771-70179c479b86"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/c7def945-1888-42fc-8d28-e1463f15da5b","type":"EvidenceLine","dc:description":"Scored 0.75pts per variant to yield 1.5pts total and prevent double-counting for homozygous variant","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c7def945-1888-42fc-8d28-e1463f15da5b_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/06392ce9-0835-4880-a67a-de044430eec6_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/06392ce9-0835-4880-a67a-de044430eec6","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9054950","rdfs:label":"GM11604","allele":{"id":"https://genegraph.clinicalgenome.org/r/4c0a2ea2-a7e3-4e40-aade-1cbe5ad967e5","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000434.4(NEU1):c.4_7dup (p.Gly3?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2573320516"}},"firstTestingMethod":"PCR","previousTesting":false,"secondTestingMethod":"SSCP","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/633394f1-7f86-4bf8-8d7b-34e8f67be164_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9054950","allele":{"id":"https://genegraph.clinicalgenome.org/r/4c0a2ea2-a7e3-4e40-aade-1cbe5ad967e5"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/633394f1-7f86-4bf8-8d7b-34e8f67be164","type":"EvidenceLine","dc:description":"Scored 0.75pts per variant to yield 1.5pts total and prevent double-counting for homozygous variant","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/633394f1-7f86-4bf8-8d7b-34e8f67be164_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/9324389c-b8cb-439f-9384-d636a02c2af5_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9324389c-b8cb-439f-9384-d636a02c2af5","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11470272","rdfs:label":"Patient 1 - Penzel","allele":{"id":"https://genegraph.clinicalgenome.org/r/ef8b607b-fb23-43a2-80f0-189588c5e3bd","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000434.4(NEU1):c.1021+1G>C","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/2455"}},"firstTestingMethod":"PCR","previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/0d7057c3-83d4-4313-8140-b1b295217c93_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11470272","allele":{"id":"https://genegraph.clinicalgenome.org/r/ef8b607b-fb23-43a2-80f0-189588c5e3bd"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/0d7057c3-83d4-4313-8140-b1b295217c93","type":"EvidenceLine","dc:description":"Scored 1pt per variant to yield 2pts total and prevent double-counting for homozygous variant.","calculatedScore":4,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0d7057c3-83d4-4313-8140-b1b295217c93_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/0d7057c3-83d4-4313-8140-b1b295217c93_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"PMID: 11470272: Shown by RT-PCR to result in exon skippping of exon 5, frameshift, and premature termination at amino acid position 268, with NMD predicted","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/fe83dc85-f240-4eec-8526-2e532c8f32f4_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fe83dc85-f240-4eec-8526-2e532c8f32f4","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9054950","rdfs:label":"GMO171SA","allele":[{"id":"https://genegraph.clinicalgenome.org/r/fc20ba93-8cb0-477d-b0d4-9a49fd5ad8bc","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000434.4(NEU1):c.779T>A (p.Phe260Tyr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA212558"}},{"id":"https://genegraph.clinicalgenome.org/r/92d0c3e7-d9d3-4e8a-98e6-5a02f086368a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000434.4(NEU1):c.1088T>C (p.Leu363Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA212559"}}],"firstTestingMethod":"PCR","previousTesting":false,"secondTestingMethod":"SSCP","sex":"UnknownEthnicity","variant":[{"id":"https://genegraph.clinicalgenome.org/r/8aadc058-bcc2-4928-b098-a4e120e9eaa8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9054950","allele":{"id":"https://genegraph.clinicalgenome.org/r/92d0c3e7-d9d3-4e8a-98e6-5a02f086368a"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/133d72d0-1f85-4a5d-a1da-c2ceedab282f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9054950","allele":{"id":"https://genegraph.clinicalgenome.org/r/fc20ba93-8cb0-477d-b0d4-9a49fd5ad8bc"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/8aadc058-bcc2-4928-b098-a4e120e9eaa8","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8aadc058-bcc2-4928-b098-a4e120e9eaa8_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/8aadc058-bcc2-4928-b098-a4e120e9eaa8_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"PMID: 10767332: aberrant cellular localization confirmed by immunolabeling of COS-7 cells expressing the mutants, with the mutants showing a mostly diffuse cytoplasmic localization","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/133d72d0-1f85-4a5d-a1da-c2ceedab282f","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/133d72d0-1f85-4a5d-a1da-c2ceedab282f_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/133d72d0-1f85-4a5d-a1da-c2ceedab282f_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"PMID: 10767332: in COS-7 cells, showed <20% of wild-type sialidase enzymatic activity and showed decreased stability - (‘half-life of their enzymatic activity in cellular lysates at 37°C was ∼30 min, as compared with the 2 h half-life of the wild-type enzyme’) ","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/9a41be75-8e8b-44dc-9c6f-656c5235366b_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9a41be75-8e8b-44dc-9c6f-656c5235366b","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10767332","rdfs:label":"Patient 5","allele":{"id":"https://genegraph.clinicalgenome.org/r/00c51782-f906-4730-9375-44194f63f83a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000434.4(NEU1):c.625del (p.Glu209fs)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/2448"}},"detectionMethod":"Genetic testing via PCR amplification, cloning of amplified fragments into pCR2.1 vector, and Sanger sequencing","firstTestingMethod":"Other","previousTesting":false,"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/7ef93ad3-bcbb-46f3-9031-92ef1d6b3708_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10767332","allele":{"id":"https://genegraph.clinicalgenome.org/r/00c51782-f906-4730-9375-44194f63f83a"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/7ef93ad3-bcbb-46f3-9031-92ef1d6b3708","type":"EvidenceLine","dc:description":"Scored 0.75pts to yield 1.5pts total and prevent double-counting for homozygous variant ","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7ef93ad3-bcbb-46f3-9031-92ef1d6b3708_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/00dcddf5-256a-4132-b07c-298d703be120_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/00dcddf5-256a-4132-b07c-298d703be120","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14695530","rdfs:label":"Patient A - Pattinson","allele":[{"id":"https://genegraph.clinicalgenome.org/r/2684a9a6-e682-486d-aeeb-f73db8b59998","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000434.4(NEU1):c.893C>T (p.Ala298Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA212565"}},{"id":"https://genegraph.clinicalgenome.org/r/d48df014-830f-43f3-9d36-707dacd8cb3f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000434.4(NEU1):c.674G>C (p.Arg225Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA212564"}}],"firstTestingMethod":"PCR","previousTesting":false,"secondTestingMethod":"Restriction digest","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/e345417a-c0cd-4700-b79f-368443403d08_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14695530","allele":{"id":"https://genegraph.clinicalgenome.org/r/2684a9a6-e682-486d-aeeb-f73db8b59998"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/3edab883-db11-4b5d-9f70-b090c14d1f01_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14695530","allele":{"id":"https://genegraph.clinicalgenome.org/r/d48df014-830f-43f3-9d36-707dacd8cb3f"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/3edab883-db11-4b5d-9f70-b090c14d1f01","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3edab883-db11-4b5d-9f70-b090c14d1f01_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/3edab883-db11-4b5d-9f70-b090c14d1f01_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"PMID: 14695530: in a recombinant adenovirus vector expression system, shown to result in undetectable sialidase enzymatic activity","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/e345417a-c0cd-4700-b79f-368443403d08","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e345417a-c0cd-4700-b79f-368443403d08_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/e345417a-c0cd-4700-b79f-368443403d08_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"PMID: 14695530: in a recombinant adenovirus vector expression system, shown to result in undetectable sialidase enzymatic activity","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":10233,"specifiedBy":"GeneValidityCriteria9","strengthScore":18,"subject":{"id":"https://genegraph.clinicalgenome.org/r/Vlp3KBNCXMQ","type":"GeneValidityProposition","disease":"obo:MONDO_0017734","gene":"hgnc:7758","modeOfInheritance":"obo:HP_0000007"},"version":"1.3","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_01f588c4-4fef-493d-b5e0-a76fb9492244-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}